Thomas Malley, Director at OvaScience, Inc. (OVAS), bought 5,000 shares at $28.50 ($143K) on 2015-04-08, disclosed to the SEC on 2015-04-09.
Open-market purchase of $142k OVAS by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| BGNE | BUY | 2016-11-28 | $960K | — | Filing → |
| KURA | BUY | 2015-12-17 | $400K | — | Filing → |
| OVAS | BUY | 2015-01-15 | $1.8M | — | Filing → |